Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19196673 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Cetuximab, Capecitabine, Oxaliplatin and Bevacizumab in Advanced Colorectal Cancer
Condition: Colorectal Cancer
Interventions: Drug: 21Capecitabine + bevacizumab + oxaliplatin;   Drug: 1Capecitabine + oxaliplatin + bevacizumab + cetuximab

Indicates status has not been verified in more than two years